|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
|
|---|---|---|
| Revenue | ||
| Operating expenses/(income) | ||
| Cost of revenue | ||
| Sales and marketing expenses (including related party transactions of $1,833,486 and $1,011,119, see note 14) | ||
| General and administrative expenses (including related party transactions of $8,120,684 and $68,413,399, see note 14) | ||
| Other operating expenses | ||
| Depreciation and amortization expenses | ||
| Research and development expenses | ||
| Other operating (income)/expense, net | ||
| Total operating expenses/(income) | ||
| Operating loss | ||
| Other (expense)/income | ||
| Interest expense | ||
| (Loss)/gain on derivatives | ||
| Loss on extinguishment | ||
| Gain on revaluation of financial asset | ||
| Gain on bargain purchase | ||
| Impairment loss | ||
| Other non-operating income (expense), net | ||
| Total other expenses, net | ||
| Loss before provision for income taxes | ||
| Provision for income taxes | ||
| Net loss and comprehensive loss | ||
| Net loss per share, basic | ||
| Net loss per share, diluted | ||
| Weighted average shares, basic | ||
| Weighted average shares, diluted |
Loading...
